Emcure Pharmaceuticals Ltd on Tuesday reported a 24 per cent increase in consolidated net profit at ₹243.74 crore in the ...
The rise in profits was attributed to the robust performance in international markets and growth in new launches from ...
Emcure Pharmaceuticals reported a 23.6% rise in Q4 net profit to Rs 244 crore, with revenue growing 16.7% to Rs 2,470 crore, ...
Overseas sales outpace domestic growth; company scales injectables, biosimilars, expands in Europe, Canada ...
The board has also recommended a final dividend of Rs 3.6 per fully paid-up equity share of Rs 10 each for the financial year ...
https://www.thehindubusinessline.com/companies/bain-capital-sells-nearly-1-stake-in-emcure-pharma-for-289-crore/article70923767.ece Copy Global investment firm Bain ...
The company had posted a consolidated net profit of ₹197.24 crore in the corresponding quarter last fiscal, Emcure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results